BN Stock Analysis: Danone | PA
Packaged Foods | PA, France | Market Cap: 37.860m EUR | 12M Return: -19.9% | FR0000120644 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 78.6M
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Danone S.A. (PA: BN) is a Paris-headquartered global food and beverage company, incorporated in 1899 and operating across Europe, North America, Asia, Latin America, Africa, the Middle East, and CIS countries. The company runs three business segments: Essential Dairy & Plant-Based, Specialized Nutrition, and Waters. Its product portfolio spans yogurts, dairy, coffee, plant-based items, ice cream, and cheese, alongside infant formula, medical nutrition, and tube-feeding products. It also markets mineral water, flavored water, fruit juices, and vitamin-enriched drinks.
Danone distributes its products through retail chains, traditional outlets, convenience stores, hotels, restaurants, coffee outlets, hospitals, clinics, pharmacies, and e-commerce channels, marketing them under a broad brand portfolio including Activia, Alpro, Aptamil, evian, Volvic, Nutricia, Oikos, Silk, and Cow & Gate. The company is a major player in the consumer staples sector, specifically within packaged foods and meats, and is classified as a large-cap stock with a market capitalization of approximately $42.9 billion USD.
- Alpro plant-based sales accelerate on protein demand and pricing
- Specialized Nutrition margins recover on Aptamil and China rebound
- Waters segment volume decline pressures revenue and category mix
| Net Income: 1.96b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -1.58 > 1.0 |
| NWC/Revenue: -1.98% < 20% (prev -2.63%; Δ 0.65% < -1%) |
| CFO/TA 0.07 > 3% & CFO 3.52b > Net Income 1.96b |
| Net Debt (9.99b) to EBITDA (4.39b): 2.28 < 3 |
| Current Ratio: 0.97 > 1.5 & < 3 |
| Outstanding Shares: last quarter (643.1m) vs 12m ago -0.05% < -2% |
| Gross Margin: 43.95% > 18% (prev 50.47%; Δ -6.53% > 0.5%) |
| Asset Turnover: 59.50% > 50% (prev 62.52%; Δ -3.02% > 0%) |
| Interest Coverage Ratio: 5.74 > 6 (EBIT TTM 3.14b / Interest Expense TTM 547.0m) |
| A: -0.01 (Total Current Assets 16.1b - Total Current Liabilities 16.6b) / Total Assets 48.6b |
| B: 0.38 (Retained Earnings 18.5b / Total Assets 48.6b) |
| C: 0.07 (EBIT TTM 3.14b / Avg Total Assets 46.2b) |
| D: 0.57 (Book Value of Equity 17.6b / Total Liabilities 30.9b) |
| Altman-Z'' = 2.22 = BBB |
| DSRI: 1.05 (Receivables 3.39b/3.22b, Revenue 27.5b/27.4b) |
| GMI: 1.15 (GM 50.47% / 43.95%) |
| AQI: 0.95 (AQ_t 0.54 / AQ_t-1 0.56) |
| SGI: 1.00 (Revenue 27.5b / 27.4b) |
| TATA: -0.03 (NI 1.96b - CFO 3.52b) / TA 48.6b) |
| Beneish M = -2.88 (Cap -4..+1) = A |
As of October 11, 2026, the stock is trading at EUR 58.70 with a total of 1,168,698 shares traded. Over the past week, the price has changed by -0.71%, over one month by -6.77%, over three months by -18.95% and over the past year by -19.90%.
Current recommended Stop Loss: 57.30 (which is 2.4% or 1.3 ATR below the current price).
Danone has no consensus analysts rating.
P/E Trailing = 19.4636
P/E Forward = 14.5138
P/S = 1.3776
P/B = 2.2064
P/EG = 1.409
Revenue TTM = 27.5b EUR
EBIT TTM = 3.14b EUR
EBITDA TTM = 4.39b EUR
Long Term Debt = 9.99b EUR (from longTermDebt, last quarter)
Short Term Debt = 6.50b EUR (from shortTermDebt, last quarter)
Debt = 18.3b EUR (from shortLongTermDebtTotal, last quarter) + Leases 902.0m
Net Debt = 9.99b EUR (calculated: Debt 18.3b - CCE 8.34b)
Enterprise Value = 47.8b EUR (37.9b + Debt 18.3b - CCE 8.34b)
Interest Coverage Ratio = 5.74 (Ebit TTM 3.14b / Interest Expense TTM 547.0m)
EV/FCF = 19.76x (Enterprise Value 47.8b / FCF TTM 2.42b)
FCF Yield = 5.06% (FCF TTM 2.42b / Enterprise Value 47.8b)
FCF Margin = 8.81% (FCF TTM 2.42b / Revenue TTM 27.5b)
Net Margin = 7.12% (Net Income TTM 1.96b / Revenue TTM 27.5b)
Gross Margin = 43.95% ((Revenue TTM 27.5b - Cost of Revenue TTM 15.4b) / Revenue TTM)
Gross Margin QoQ = 37.74% (prev 50.33%)
Tobins Q-Ratio = 0.98 (Enterprise Value 47.8b / Total Assets 48.6b)
Interest Expense / Debt = 2.98% (Interest Expense 547.0m / Debt 18.3b)
Taxrate = 28.48% (802.0m / 2.82b)
NOPAT = 2.24b (EBIT 3.14b * (1 - 28.48%))
Current Ratio = 0.97 (Total Current Assets 16.1b / Total Current Liabilities 16.6b)
Debt / Equity = 1.04 (Debt 18.3b / totalStockholderEquity, last quarter 17.6b)
Debt / EBITDA = 2.28 (Net Debt 9.99b / EBITDA 4.39b)
Debt / FCF = 4.12 (Net Debt 9.99b / FCF TTM 2.42b)
Total Stockholder Equity = 17.0b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.24% (Net Income 1.96b / Total Assets 48.6b)
RoE = 11.49% (Net Income TTM 1.96b / Total Stockholder Equity 17.0b)
RoCE = 11.61% (EBIT 3.14b / Capital Employed (Equity 17.0b + L.T.Debt 9.99b))
RoIC = 6.04% (NOPAT 2.24b / Invested Capital 37.2b)
WACC = 3.80% (E(37.9b)/V(56.2b) * Re(4.61%) + D(18.3b)/V(56.2b) * Rd(2.98%) * (1-Tc(0.28)))
Discount Rate = 4.61% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 58.30 | Cagr: 0.30%
[DCF] Terminal Value 73.10% ; FCFF base≈2.60b ; Y1≈2.28b ; Y5≈1.84b
[DCF] Fair Price = 30.41 (EV 29.6b - Net Debt 9.99b = Equity 19.6b / Shares 644.1m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 34.75 | EPS CAGR: 20.37% | SUE: N/A | # QB: 0
Revenue Correlation: -17.52 | Revenue CAGR: -0.10% | SUE: 1.11 | # QB: 1
EPS current Quarter (2026-03-31): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS next Quarter (2026-06-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=3.93 | Chg30d=-0.29% | Revisions=+40% | GrowthEPS=+3.3% | GrowthRev=+3.2%
EPS next Year (2027-12-31): EPS=4.23 | Chg30d=+0.00% | Revisions=-40% | GrowthEPS=+7.6% | GrowthRev=+4.7%
[Analyst] Revisions Ratio: +0% (up=2, down=2)